ABI1 and prostate cancer: Additionally, a study of 505 patients with prostate cancer found that low ABI1 expression is associated with increased cancer recurrence, metastasis, and death, linked to activation of epithelial-mesenchymal transition (EMT) pathways and non-canonical WNT signaling.